Cell APC and Open Access: The $11,400 Fee, Elsevier Agreements, and Your Real Options

Cell operates as a hybrid journal with two tracks:

1. Subscription track (default, $0): Your article is published behind the Elsevier/Cell Press paywall. Institutional libraries pay for access. You pay nothing.
2. Gold open access track ($11,400): Your article is immediately free to read for everyone. You choose a Creative Commons license (CC BY or CC BY-NC-ND).

This is the same structure as Nature, but with one critical difference: institutional coverage.

Here's the problem most researchers don't discover until after acceptance: Cell Press journals are excluded from the vast majority of Elsevier's Read & Publish agreements.

Elsevier has negotiated transformative agreements with hundreds of institutions worldwide. These deals cover APCs for more than 1,800 Elsevier "core hybrid journals." But the fine print consistently excludes Cell Press, Lancet, and Clinics titles.

What this means in practice:

Some institutions have recently negotiated separate Cell Press inclusion into their Elsevier agreements. UCLA's UC-Elsevier agreement, for instance, was expanded in 2025 to include Cell Press and Lancet titles, with the library covering a portion of the APC. But this is the exception. Most institutions' Elsevier deals still exclude Cell Press.

Before choosing OA at Cell, check with your library. Specifically ask: "Does our Elsevier agreement cover Cell Press titles?" Don't assume it does because your other Elsevier publications were covered.

Cell Press has a less transparent waiver system than Springer Nature or AAAS. Here's what's available:

Geographical pricing (GPOA):

Elsevier's Geographical Pricing for Open Access program applies to Cell Press journals. Authors from lower-income countries (as classified by Elsevier's internal tier system) receive discounted APCs. The discount varies by country tier and can range from 25% to 100% off.

Unlike Springer Nature's automatic waiver for Research4Life countries, Elsevier's GPOA is applied during the payment process based on your institutional affiliation. The system calculates a "personalized APC" that accounts for your country, institution, and any applicable agreements.

Financial hardship waivers:

Cell Press considers case-by-case waiver requests. If you can't afford the APC and no institutional support exists, contact the editorial office after acceptance. The success rate for hardship waivers at Cell Press is not publicly disclosed, and approval appears to be less systematic than at Springer Nature.

Society membership discounts:

Unlike some publishers that offer society member discounts, Cell Press does not widely advertise membership-based APC reductions. The American Society for Cell Biology (ASCB) does not have a formal APC discount arrangement with Cell Press.

If Cell at $11,400 feels steep, here's how it compares to the rest of the Cell Press family:

The pattern: flagship and specialty hybrid journals cluster around $9,350-$11,400, while the fully OA titles (Cell Reports, Cell Reports Medicine, Cell Genomics) are $5,790.

Cell supports both CC BY and CC BY-NC-ND licenses. Plan S funders require CC BY. If your funder is a cOAlition S member, you must select CC BY during the licensing stage. The CC BY-NC-ND option does not satisfy Plan S.

For NIH-funded researchers: Cell allows deposit of the accepted manuscript in PubMed Central after a 12-month embargo. If you don't need immediate OA, this route is free.

Cell doesn't charge page fees, color figure charges, or submission fees. The APC is the only publication charge. But watch for these:

• Tax: VAT or other sales tax applies in many jurisdictions. In the EU, this can add 15-25% to the listed price, making the effective cost $13,000-$14,000.
• Graphical abstract: Cell requires a graphical abstract for all research articles. Creating this isn't a journal fee, but if you hire a scientific illustrator, budget $200-$500.
• License lock-in: If you select CC BY-NC-ND at the licensing stage and later realize your funder requires CC BY, changing the license post-publication requires publisher approval and isn't guaranteed.
• Embargo timing: If you publish via the subscription track and deposit in PMC, the 12-month clock starts from the publication date, not the acceptance date. Papers that spend months in production have a longer total wait.

Cell's APC situation is straightforward but inconvenient. You have two options:

1. Publish for free via subscription. Your paper is in Cell, fully indexed, fully citable. It goes behind the paywall. After 12 months, you can deposit in PMC.
2. Pay $11,400 for immediate OA. Your paper is free to read from day one. Check first whether your institution or funder covers this.

The most common mistake: assuming your Elsevier institutional deal covers Cell Press. It probably doesn't. Ask your library before you commit to OA.

If you're deciding whether Cell is the right target for your manuscript, the APC is secondary to getting past the editors. Cell desk-rejects roughly 70% of submissions, and the editorial bar is whether your findings change how biologists think about a fundamental process. Run a free readiness scan to check your paper's fit before submitting.